⏳ Fetching live dividend data...
Home › Calculator › HTBX Dividend Calculator 2026
Heat Biologics, Inc. · AMEX
Price: $2.38 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in HTBX → $169642090245.79M in 10 years · $14,120,431,368,144,146.00/month
Heat Biologics, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which has completed enrollment in a Phase II clinical trial to treat patients with advanced non-small cell lung cancer; and HS-130 that is in Phase I clinical trial for the treatment of advanced solid tumors. Its products also include PTX-35, a novel T-cell co-stimulator agonist antibody targeting DR3/TNFRSF25 that is in Phase I clinical trial; DR3/TNFRSF25 for various immunotherapy approaches; and COVID-19 vaccine, which is in preclinical stage. Heat Biologics, Inc. has a collaboration with Dr. James Shapiro at University of Alberta to manufacture surrogate mouse version of PTX-35. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open HTBX position with:
Real after-tax yield depends on where you live and how you hold HTBX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 84.03% | 81.23% | $8,403 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 71.43% | 68.63% | $7,143 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 67.22% | 64.42% | $6,722 / yr |
| 🇬🇧 UK ISA | 0% | 84.03% | 81.23% | $8,403 / yr |
| 🇬🇧 UK Taxable | 8.75% | 76.68% | 73.88% | $7,668 / yr |
| 🇨🇦 TFSA | 0% | 84.03% | 81.23% | $8,403 / yr |
| 🇨🇦 CA Taxable | 25% | 63.02% | 60.22% | $6,302 / yr |
| 🇦🇺 Super (pension) | 15% | 71.43% | 68.63% | $7,143 / yr |
| 🇦🇺 AU Taxable | 30% | 58.82% | 56.02% | $5,882 / yr |
| 🇩🇪 DE Taxable | 26.375% | 61.87% | 59.07% | $6,187 / yr |
| 🇫🇷 FR Taxable | 30% | 58.82% | 56.02% | $5,882 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
HTBX pays quarterly — 4 times per year. Next ex-div: TBD.
How HTBX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HTBX sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2021-12-30 | 32,467 | $4.06 | $131.8K | ||
| J-Other | 2021-12-30 | 32,467 | $4.06 | $131.8K | ||
| A-Award | 2021-12-13 | 32,467 | $4.06 | $131.8K | ||
| A-Award | 2021-12-13 | 68,807 | $4.06 | $279.4K | ||
| A-Award | 2021-01-04 | 65,217 | $5.67 | $369.8K | ||
| A-Award | 2021-01-04 | 51,487 | $5.67 | $291.9K | ||
| Sale | 2020-11-12 | 103,304 | $1.03 | $106.4K | ||
| M-Exempt | 2020-08-13 | 15,625 | $0.52 | $8.1K | ||
| M-Exempt | 2020-08-13 | 15,625 | $0.52 | $8.1K | ||
| F-InKind | 2020-08-13 | 4,440 | $1.83 | $8.1K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HTBX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →